Literature DB >> 23824108

High-dose radiotherapy alone for patients with T4-stage laryngeal cancer.

A Mucha-Małecka1, K Składowski.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this retrospective study was to report on the efficacy of radiotherapy alone in patients with T4-stage laryngeal cancer and to establish the prognostic value of (a) the size and location of the extralaryngeal tumor extensions and (b) of emergency tracheostomy. PATIENTS AND METHODS: A group of 114 patients were treated with definitive radiotherapy between 1990 and 1996. The piriform recess was involved in 37 cases (33 %), the base of the tongue and glosso-epiglottic vallecula in 34 cases (30 %), and the hypopharyngeal wall in 10 cases (9 %). In 16 cases (14 %), emergency tracheostomy was performed before radiotherapy. The mean total dose was 68 Gy (range, 60-77.6 Gy). The mean treatment time was 49 days (range, 42-74 days).
RESULTS: Actuarial 3-year local control (LC) was noted in 42 % of patients, disease-free survival (DFS) in 35 %, and overall survival (OS) in 40 %. The best prognosis was for the lesion suspected of cartilage infiltration: 56 % 3-year LC. The worst results were noted in the cases with massive infiltrations spreading from the larynx through the hypopharynx: 13 % 3-year LC. Emergency tracheostomy before radiotherapy was significantly connected with the worst treatment results (p = 0.000): 3-year LC in patients with tracheostomy was 0 % vs. 48 % in patients without tracheostomy.
CONCLUSION: Conventional radiotherapy of T4 laryngeal cancer is a method of treatment with limited effectiveness. The efficacy of radiotherapy is dependent on the location and extent of extralaryngeal infiltrations. Emergency tracheostomy is a prognostic factor connected with the worst prognosis.

Entities:  

Mesh:

Year:  2013        PMID: 23824108     DOI: 10.1007/s00066-013-0396-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  47 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.

Authors:  J Cvek; J Kubes; E Skacelikova; B Otahal; P Kominek; M Halamka; D Feltl
Journal:  Strahlenther Onkol       Date:  2012-06-01       Impact factor: 3.621

3.  Reasons for irradiation failure in squamous cell carcinoma of the larynx.

Authors:  G H Fletcher; R D Lindberg; A Hamberger; J C Horiot
Journal:  Laryngoscope       Date:  1975-06       Impact factor: 3.325

4.  [The incidence of laryngeal cancer among males in the upper Silesia].

Authors:  B Zemła; M Weryński; J Sowa; L Markiewicz; J Ihnatowicz
Journal:  Otolaryngol Pol       Date:  1996

5.  T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage.

Authors:  J T Parsons; W M Mendenhall; S P Stringer; N J Cassisi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

6.  The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx.

Authors:  B Maciejewski; G Preuss-Bayer; K R Trott
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-03       Impact factor: 7.038

7.  Squamous cell carcinoma of the supraglottic larynx treated with radical irradiation: analysis of treatment parameters and results.

Authors:  W M Mendenhall; R R Million; N J Cassisi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-12       Impact factor: 7.038

Review 8.  T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone.

Authors:  W M Mendenhall
Journal:  Semin Radiat Oncol       Date:  1998-10       Impact factor: 5.934

9.  The problem of neck relapse in early stage supraglottic cancer--results of different treatment modalities for the clinically negative neck.

Authors:  P Levendag; B Vikram
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-11       Impact factor: 7.038

10.  Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival.

Authors:  J Overgaard; H S Hansen; K Jørgensen; M Hjelm Hansen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

View more
  3 in total

1.  Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.

Authors:  D Alterio; P Franco; G Numico; L Licitra; M Cossu Rocca; A Ferrari; C Pinto; E G Russi; U Ricardi; B A Jereczek Fossa
Journal:  Med Oncol       Date:  2016-06-11       Impact factor: 3.064

2.  Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors.

Authors:  Tomasz Skóra; Jadwiga Nowak-Sadzikowska; Anna Mucha-Małecka; Bogumiła Szyszka-Charewicz; Jerzy Jakubowicz; Bogdan Gliński
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-29       Impact factor: 2.503

3.  Radiotherapy for locally advanced resectable T3-T4 laryngeal cancer-does laryngeal preservation strategy compromise survival?

Authors:  Hideya Yamazaki; Gen Suzuki; Satoaki Nakamura; Shigeru Hirano; Ken Yoshida; Koji Konishi; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2018-01-01       Impact factor: 2.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.